GE Operating Cash Flow (Statement)

GE Aerospace · Operating Cash Flow (Statement)

GE logo

GE Operating Cash Flow (Statement)

Latest reported$9.45B
GE TTM Cash from Operations ($9.04B → $9.45B)
High-resolution chart · PNG

GE operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

GE Aerospace Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
9,451,000,000
9,800,000,000
8,851,000,000
8,537,000,000
7,553,000,000
6,560,000,000
5,227,000,000
4,710,000,000
6,554,000,000
6,869,000,000
6,441,000,000
5,190,000,000
6,548,000,000
6,148,000,000
6,213,000,000
5,916,000,000
3,849,000,000
4,767,000,000
4,735,000,000
3,332,000,000
4,534,000,000
3,528,000,000
1,852,000,000
3,597,000,000
6,702,000,000
7,208,000,000
8,436,000,000
8,772,000,000
10,600,000,000
5,845,000,000
4,791,000,000
4,981,000,000
-446,000,000
3,325,000,000
6,426,000,000
6,423,000,000
4,912,000,000
5,017,000,000
-612,000,000
-277,000,000
4,838,000,000
4,637,000,000
14,448,000,000
19,894,000,000
24,615,000,000
29,889,000,000
28,839,000,000
27,710,000,000
27,662,000,000
26,858,000,000
28,930,000,000
28,579,000,000
28,415,000,000
29,045,000,000
29,475,000,000
31,331,000,000
29,214,000,000
32,436,000,000
32,129,000,000
33,359,000,000
33,870,000,000
34,736,000,000
36,725,000,000
36,123,000,000
37,118,000,000
35,567,000,000
32,151,000,000
24,593,000,000
34,251,000,000
36,064,000,000
41,346,000,000
48,601,000,000
45,599,000,000
45,625,000,000
47,816,000,000
45,967,000,000
37,620,000,000
36,874,000,000
30,079,000,000
30,646,000,000
29,535,000,000
34,317,000,000
33,298,000,000
37,641,000,000
39,306,000,000
34,660,000,000
38,325,000,000
36,484,000,000
34,364,000,000
35,843,000,000
34,801,000,000
30,289,000,000
31,305,000,000
30,440,000,000
27,598,000,000
29,488,000,000
29,612,000,000
26,773,000,000
33,134,000,000
32,195,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.